Active ingredientIbandronate Sodium MonohydrateCat. No. P-I002-001CAS 138926-19-9Family · Pharmaceutical analytical standards
Ibandronate
A nitrogen-containing bisphosphonate that slows bone resorption, approved in the United States in 2003 for postmenopausal osteoporosis. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.
Did you know?In 2006 its injectable form became the first intravenous treatment for osteoporosis available in the United States.
Go to the active ingredient →Active ingredientIbandronate Sodium MonohydrateCat. No. P-I002-001CAS 138926-19-9
Active ingredientIbandronate Sodium SaltCat. No. P-I002-002CAS 138844-81-2
Pharmacopoeial impurityIbandronate Sodium EP Impurity CCat. No. P-I002-003CAS 905808-25-5
Pharmacopoeial impurityIbandronate Sodium EP Impurity C Sodium saltCat. No. P-I002-004CAS 953805-81-7
Pharmacopoeial impurityIbandronate USP Related Compound A HydrochlorideCat. No. P-I002-005CAS 625120-81-2
Isotopically labelledIbandronic Acid-13C-d3Cat. No. P-I002-006CAS 1261734-84-2
Isotopically labelledIbandronic Acid-d3Cat. No. P-I002-007CAS 1130899-41-0
Nitrosamine3-(Methylnitrosoamino) PropanalCat. No. P-I002-008CAS 85502-23-4
Nitrosamine3-(Methylnitrosoamino) PropanenitrileCat. No. P-I002-009CAS 60153-49-3
NitrosamineN-Nitroso Desmethyl IbandronateCat. No. P-I002-010
Impurity3-(methylamino)propanenitrileCat. No. P-I002-011CAS 693-05-0
Impurity3-(Pentylamino)propanoic acid hydrochlorideCat. No. P-I002-012CAS 2377035-78-2![3-[N-Methyl(pentyl)amino]propanenitrile](https://img.vitasanlabs.com/vsl-struct/P-I002-013.svg?v=41e934f030)
Impurity3-[N-Methyl(pentyl)amino]propanenitrileCat. No. P-I002-013CAS 919491-64-8
ImpurityIbandronate Impurity 1Cat. No. P-I002-015CAS 128202-57-3
ImpurityIbandronate Impurity 2 HydrochlorideCat. No. P-I002-016
ImpurityIbandronate Impurity 3Cat. No. P-I002-017
ImpurityIbandronate Impurity 4Cat. No. P-I002-018CAS 1346601-22-6
ImpurityIbandronate Impurity 4 Sodium SaltCat. No. P-I002-019CAS 1797984-36-1
ImpurityIbandronate Impurity 5Cat. No. P-I002-020
ImpurityIbandronate Impurity 6Cat. No. P-I002-021
Active ingredientIbandronic AcidCat. No. P-I002-022CAS 114084-78-5
ImpurityN-benzyl-N-methylpentan-1-amineCat. No. P-I002-023CAS 77223-58-6
ImpurityN-Methyl-N-(2-methylbutyl)-beta-alanine HydrochlorideCat. No. P-I002-024CAS 2512208-74-9
ImpurityOlpadronic AcidCat. No. P-I002-025CAS 63132-39-8
ImpurityTetramethyl IbandronateCat. No. P-I002-026CAS 1076199-42-2No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceIbandronate sodium monohydrate CRSEDQM code Y0002248Family IbandronateNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.